focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.90
Bid: 1.80
Ask: 2.00
Change: -1.15 (-37.70%)
Spread: 0.20 (11.111%)
Open: 2.70
High: 2.70
Low: 1.90
Prev. Close: 3.05
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Eco Animal expects earnings below consensus

Tue, 15th Mar 2022 10:53

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

ValiRx PLC, up 14% at 23.61 pence, 12-month range 17.26p-63p. The cancer and women's health treatment developer says it is assessing options to acquire capabilities and infrastructure to create a "more efficient and effective" translational drug development service. Says revenue generated from providing pre-clinical development services would enable continued investment in advanced testing and analysis technology and support the progression of ValiRx in-house pipeline projects.

----------

Tlou Energy Ltd, up 13% at 2.14p, 12-month change 1.57p-4.9p. The power company says contract for the construction of the transmission line to connect the Lesedi power project to Botswana's electricity grid has been signed. Botswana-based Zismo Engineering Pty Ltd has been engaged to construct the line, and expects to mobilise plant and equipment on site in the coming weeks.

----------

AIM - LOSERS

----------

Mobile Streams PLC, down 20% at 0.3155p, 12-month range 0.2p-0.71p. The mobile content provider raises GBP1.2 million in placing priced at 0.30p per share. Funds to support company's growth and to create a new joint venture partnership with Gfinity PLC for Mobilegaming.com. "The company is working to agree the terms of the joint venture and expects to announce the conclusion of the agreement shortly," it says. Gfinity shares rise 11%.

----------

Eco Animal Health Group PLC, down 18% at 123.49p, 12-month change 116.55p-405p. The pet and livestock pharmaceuticals firm expects earnings before interest, tax, depreciation and amortisation for year ending March 31 to be 15% to 20% below consensus expectations amid investment. "The pork commodity price in China continues to be volatile but we are pleased with recent trading and our expectation of meeting revenue consensus is an important indicator of a return to more stable trading conditions," says Chief Executive Marc Loomes.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
7 Jun 2016 09:19

ValiRx Highlights Progress With VAL201 Lead Compound, VAL401 Venture

Read more
19 May 2016 15:44

ValiRx updates market on 'significant' 2015

(ShareCast News) - Lifesciences company ValiRx reported on a "significant year" on Thursday, talking up its capital restructure and technical advancements in the 2015 calendar year. The AIM-traded firm, which focuses on cancer therapeutics and diagnostics for personalised medicine, said its Phase I/

Read more
19 May 2016 10:29

ValiRx Loss Narrows As Progress Is Made On Cancer Compounds

Read more
19 May 2016 09:23

ValiRx Says ValiSeek Begins Manufacturing VAL401 For Clinical Trial

Read more
29 Apr 2016 07:50

ValiRx Says ValiSeek Gets US Patent For VAL401 In Adenocarcinoma

Read more
19 Apr 2016 14:45

ValiRx Shares Fall After Bracknor Converts GBP200,000 Of Loan Notes (ALLISS)

Read more
1 Apr 2016 14:28

ValiRx Receives Conversion Notice For GBP90,000 From Bracknor (ALLISS)

Read more
21 Mar 2016 08:29

ValiRx Strikes GBP4 Million Convertible Funding Deal With Bracknor (ALLISS)

Read more
17 Mar 2016 09:07

ValiRx Hires Consultancy Firm Burns McClellan To Boost US Profile

Read more
17 Feb 2016 13:04

ValiRx Raises Funds To Back Ongoing Drug Trials (ALLISS)

Read more
16 Feb 2016 13:17

ValiRx achieves success in latest VAL201 trial

(ShareCast News) - ValiRx was pressing ahead with the trial process for its VAL201 trial treatment on Tuesday, following positive results from the most recent tranche of test patients. The AIM-traded life science company, with a focus on cancer diagnostics and therapeutics for personalised medicine,

Read more
16 Feb 2016 09:16

ValiRx Says Final Dose Escalation For VAL201 Trials Approved

Read more
9 Feb 2016 14:17

ValiRx confident in two ongoing clinical trials

(ShareCast News) - ValiRx was confident in the potential of two of its compounds on Tuesday, in its quarterly update on its ongoing clinical trials. The AIM-traded life science firm, with a focus on cancer diagnostics and therapeutics for personalised medicine, said that recent testing had shown VAL

Read more
9 Feb 2016 10:42

WINNERS & LOSERS SUMMARY: Bond Disclosure Sends Legal & General Higher

Read more
9 Feb 2016 09:15

ValiRx Shares Rise After Positive Clinical Trial News For VAL201

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.